Poole Jonathan 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Jul 24, 2017
Insider Transaction Report
Form 4
Poole Jonathan
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-07-24$3.09/sh+45,000$139,050→ 84,247 total - Sale
Common Stock
2017-07-24$6.00/sh−45,000$270,000→ 39,247 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-07-24−45,000→ 90,000 totalExercise: $3.09Exp: 2026-02-01→ Common Stock (45,000 underlying)
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2017 by the reporting person.
- [F2]These shares were sold in multiple transactions at a price of $6.00. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold.
- [F3]The option was granted on 2/2/2016 and vests in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.